Assertio Therapeutics
ASRT
#9671
Rank
C$79.56 M
Marketcap
C$12.40
Share price
-5.04%
Change (1 day)
878.21%
Change (1 year)

Earnings for Assertio Therapeutics (ASRT)

Earnings in 2025 (TTM): -C$37.21 Million

According to Assertio Therapeutics 's latest financial reports the company's current earnings are C$0.13 Billion. In 2024 the company made an earning of -C$25.94 Million, an increase over its 2023 earnings that were of -C$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Assertio Therapeutics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$37.21 Million43.45%
2024 -C$25.94 Million-92.46%
2023 -C$0.35 Billion-744.93%
2022 C$53.34 M304.52%
2021 C$13.18 M-132.53%
2020 -C$40.54 Million-81.97%
2019 -C$0.23 Billion-253.57%
2018 C$0.14 B-451.81%
2017 -C$41.62 Million-258.05%
2016 C$26.32 M-138.59%
2015 -C$68.24 Million-121.01%
2014 C$0.32 B2275.01%
2013 C$13.67 M-133.45%
2012 -C$40.88 Million-141.87%
2011 C$97.61 M1496.17%
2010 C$6.11 M-121.23%
2009 -C$28.81 Million22.98%
2008 -C$23.42 Million-135.96%
2007 C$65.12 M
2003 -C$40.28 Million
2000 -C$10.61 Million43.5%
1999 -C$7.39 Million58.6%
1998 -C$4.66 Million580%
1997 -C$0.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-C$24.88 Million-31.08%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-C$0.22 Billion 505.39%๐Ÿ‡บ๐Ÿ‡ธ USA